1-15 of 15
Kevin Mills
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

National Hemophilia Foundation Champions a National Research Blueprint Defining a Community-Coordinated Research Ecosystem to Accelerate Progress in Inherited Bleeding Disorders

Michelle Witkop, Maria E. Santaella, Michael Recht, Keri Norris, Brett Spitale, Esmeralda Vasquez, Donna DiMichele, Kevin Mills
Journal: Blood
Blood (2022) 140 (Supplement 1): 5021–5022.
https://doi.org/10.1182/blood-2022-170842
Published: 2022
Journal Articles

National Hemophilia Foundation Convenes Diverse Community Voices to Define an Actionable National Research Blueprint for Inherited Bleeding Disorders

Michelle L Witkop, Michael Recht, Donna DiMichele, Kevin Mills, Leonard A. Valentino, Maria E Santaella
Journal: Blood
Blood (2021) 138 (Supplement 1): 4952.
https://doi.org/10.1182/blood-2021-149518
Published: 2021
Journal Articles

National Hemophilia Foundation Enlists Diverse Patient Voices to Inform a National Research Blueprint for Inherited Bleeding Disorders

Maria E Santaella, Michelle L Witkop, Kevin Mills, Michael Recht, Donna DiMichele, Leonard A. Valentino
Journal: Blood
Blood (2021) 138 (Supplement 1): 1904.
https://doi.org/10.1182/blood-2021-147857
Published: 2021
Journal Articles

Targeting Homologous Recombination in Lymphoid Malignancies: Evaluation of Four Small Molecule Inhibitors of RAD51

Melinda Day, PhD, Tyler Maclay, Amber Cyr, Muneer G Hasham, PhD, Kin-hoe Chow, ED Keniston, Kevin Mills, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2080.
https://doi.org/10.1182/blood-2019-131747
Published: 2019
Journal Articles

CYT-0853, a Novel RAD51 Inhibitor, Modulates Immunoregulatory B-Lymphocytes

Tamar Aprahamian, PhD, ED Keniston, Jane Branca, Muneer G Hasham, PhD, Melinda Day, PhD, Kevin Mills, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2330.
https://doi.org/10.1182/blood-2019-131311
Published: 2019
Journal Articles

Ongoing Spontaneous DNA Damage Creates Synthetic Lethality Targeted By Novel RAD51 Inhibitors in Multiple Myeloma

Subodh Kumar, PhD, Maria Gkotzamanidou, MD PhD, Srikanth Talluri, PhD, Melinda Day, PhD, Mychell Neptune, Lakshmi B. Potluri, Chandraditya Chakraborty, PhD, Kevin Mills, PhD, Masood A. Shammas, PhD, Nikhil C. Munshi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4378.
https://doi.org/10.1182/blood-2019-129121
Published: 2019
Journal Articles

CYT01B, a Novel RAD51 Inhibitor, Act Synergistically with Both Targeted and Chemotherapeutic Anti-Cancer Agents

Tyler Maclay, Joseph Vacca, Casey McComas, Alfredo Castro, Melinda Day, PhD, Kevin Mills, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3963.
https://doi.org/10.1182/blood-2018-99-119373
Published: 2018
Journal Articles

Efficacy Evaluation of Liver-Directed Gene Therapy in Fabry Mice

Azadeh Kia, PhD, Jenny McIntosh, PhD, Cecilia Rosales, PhD, Paniz Hosseini, Rose Sheridan, Justyna Spiewak, Kevin Mills, Romuald Corbau, PhD, Amit C Nathwani, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2209.
https://doi.org/10.1182/blood-2018-99-116632
Published: 2018
Journal Articles

A Novel RAD51 Inhibitor, CYT01B, Shows Anti-Cancer Activity in Preclinical Models of Aid Expressing Lymphomas

Muneer G Hasham, PhD, Darryl Patrick, Leanne Bedard, Joseph Vacca, Casey McComas, Alfredo Castro, Melinda Day, PhD, Kevin Mills, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2944.
https://doi.org/10.1182/blood-2018-99-119351
Published: 2018
Journal Articles

A Small Molecule RAD51 Inhibitor Preferentially Affects Cells Expressing High Cytidine Deaminase Activity

Kevin Mills, PhD, Amber Cyr, Tyler Maclay, Melinda Day, Muneer G Hasham, PhD, Andre Khalil
Journal: Blood
Blood (2017) 130 (Supplement 1): 4627.
https://doi.org/10.1182/blood.V130.Suppl_1.4627.4627
Published: 2017
Journal Articles

Synthetic Lethality Targeting the Aid/RAD51 Axis for Treatment of AICDA-Expressing Lymphoma

Kevin Mills, PhD, Amber Cyr, Tyler Maclay, Melinda Day, Darryl Patrick, Sophie-Dorothee Clas, Muneer G Hasham, PhD, Kin-hoe Chow
Journal: Blood
Blood (2017) 130 (Supplement 1): 4628.
https://doi.org/10.1182/blood.V130.Suppl_1.4628.4628
Published: 2017
Journal Articles

RAD51 Modulators Induce Mitotic Catastrophe in Aid Expressing Cells through Multiple Pathways

Kevin Mills, PhD, Muneer Hasham, PhD, Kristin Lamont, PhD, Vivek Philip, PhD, Jane Branca
Journal: Blood
Blood (2016) 128 (22): 4721.
https://doi.org/10.1182/blood.V128.22.4721.4721
Published: 2016
Journal Articles

Changes in regulation of human monocyte proteins in response to IgG from patients with antiphospholipid syndrome

Vera M. Ripoll, Anastasia Lambrianides, Silvia S. Pierangeli, Katie Poulton, Yiannis Ioannou, Wendy E. Heywood, Kevin Mills, David S. Latchman, David A. Isenberg, Anisur Rahman, Ian P. Giles
Journal: Blood
Blood (2014) 124 (25): 3808–3816.
https://doi.org/10.1182/blood-2014-05-577569
Published: 2014
Includes: Supplemental data
Journal Articles

A Novel Automated Analysis Of Flow Cytometry Data Identifies Distinct Cell Signatures In The Immune System Of CLL Patients

Jens Rueter, MD, Vivek Philip, Krishna Karuturi, PhD, Zaher Oueida, MD, Margaret Chavaree, CTR, Petra Helbig, CCRP, Frederick Eyerer, Kevin Mills, PhD, Joel Graber, PhD
Journal: Blood
Blood (2013) 122 (21): 2864.
https://doi.org/10.1182/blood.V122.21.2864.2864
Published: 2013
Journal Articles

A Critical Role of Blockade of Cell Differentiation in BCR-ABL-Induced B-Cell Acute Lymphoblastic Leukemia (B-ALL): Basis for Superb Therapeutic Effect on B-ALL in Mice by Promotion of Pro-B Leukemic Cell Differentiation and Treatment with Imatinib.

Yiguo Hu, MD, Linghong Kong, MD, PhD, Kevin Staples, Kevin Mills, PhD, John G. Monroe, PhD, Shaoguang Li, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 844.
https://doi.org/10.1182/blood.V106.11.844.844
Published: 2005